PRECISIS GmbH: Minimally Invasive Epilepsy Treatment EASEE Receives FDA Breakthrough Device Designation
HEIDELBERG, GERMANY / ACCESSWIRE / February 22, 2022 / Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE brain
Source: finanznachrichten.de